William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 20,000 shares at $51.83 ($1.0M) on 2026-05-05, disclosed to the SEC on 2026-05-07.
Scheduled sale ($1.0M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |
| CORT | SELL | 2026-03-24 | $424K | — | Filing → |